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a  b  s  t  r  a  c  t
Tuberculosis (TB) is a contagious infectious disease caused by Mycobacterium tuberculo-
sis  (Koch’s bacillus). Co-infection with human immunodeﬁciency virus (HIV) and TB has
reached a signiﬁcant importance as a public health problem and this association has been
recognized as the most signiﬁcant event that changed “the balance between man and Koch’s
bacillus” in the last century, and has a large contribution to the risk for disease spreading.
Tuberculosis has two main standard categories of clinical manifestations: primary and sec-
ondary. Primary TB is responsible for the initial infection with lungs being the involved organ.
Oral  lesions are observed as a secondary TB clinical manifestation with most frequent sites
being hard and soft palate, tongue, lips, gums, tonsils, and salivary glands. A case of classical
TB  lesions in the oral cavity is reported, and the importance of a correct diagnosis through
careful history taking is emphasized. Treatment selection needs to be done assertively, with
great determination and building a link between patient and treatment protocol, in order
to  promote patient’s adherence.
©  2014 SECOM. Published by Elsevier España, S.L.U. This is an open access article under
the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Manifestaciónes  orales  en  pacientes  con  VIH/TB  evidenciado  a  través  de
los  Granos  de  Trélat
alabras clave:
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r  e  s  u  m  e  n
La tuberculosis (TB) es una enfermedad infecciosa contagiosa causada por Mycobacterium
tuberculosis (bacilo de Koch). La coinfección del Virus de Inmunodeﬁciencia Humana (VIH)
uberculosis oral
alud pública
con  TB son problemas de salud pública graves, además que esta asociación ha sido identiﬁ-
cado  como el evento más signiﬁcativo que cambió “el equilibrio entre el hombre y el bacilo de
Koch” en el último siglo y es crucial en el riesgo de propagación de la enfermedad. La tuber-culosis se maniﬁesta en dos estándares: primaria y secundaria; el primario es responsable
de  la infección inicial y el órgano de elección es el pulmón. Las lesiones orales se observan
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a nivel secundario y los sitios más frecuentes son el paladar duro y blando, lengua, labios,
encías, amígdalas y las glándulas salivales. Esta revisión presenta un caso con lesiones
clásicas de tuberculosis en la cavidad bucal haciendo hincapié en la importancia de un
correcto diagnóstico a través de la anamnesis. El tratamiento se debe hacer con la seguri-
dad, la determinación y la formación de enlaces que facilitan la adherencia del paciente al
tratamiento.
© 2014 SECOM. Publicado por Elsevier España, S.L.U. Este es un artículo Open Access
cia C
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Introduction
Tuberculosis (TB) is a chronic infectious granulomatous dis-
ease caused by the aerobic bacillus Mycobacterium tuberculosis,
called Koch’s bacillus discovered by Robert Koch in 1882.1–4
Tuberculosis is a major public health concern especially in
Asia and Africa, and is still among the most life-threatening
infectious diseases, resulting in high mortality risk in adults.
With a prevalence of 9.2 million new cases diagnosed, in
the world, which occurred 1.7 million tuberculosis deaths in
2006, and was possible to notice that 0.7 million cases and
0.2 million deaths were in HIV positive.5,6 The WHO  report of
2008 showed the expected incidence of 9.4 million TB cases,
about 139 cases per 100,000 individuals; This represents an
increase of 100 thousand new cases in 2007.7,8 Interestingly,
there seems to be a high rate of co-infection that includes TB
and HIV patients, responsible for almost 28% of tuberculosis
deaths.8,9 The countries with the largest number of cases in
2009 were India and China. Tuberculosis in India is a public
health problem, with a ﬁfth (21%) of all TB cases in the world.10
There is a relation between the disease intense growth with
the acquired immunodeﬁciency syndrome (AIDS) by the pop-
ulation affected, due to the T lymphocyte issue, the largest
component of the cellular immune response against M.  tuber-
culosis, causing serious implications.1,3,4 The infections are the
result of bacillus spread directly from person to person, trans-
mitted by an individual with an active disease.1,3,11
The infection is distinguished by two phases: primary and
secondary. The primary tuberculosis is mild, manifesting with
fever, chills, cough and sputum production.1,3,11 Microorgan-
isms produce initially a non-speciﬁc inﬂammatory chronic
reaction. In most individuals, primary infection results from
a local ﬁber calciﬁed nodule, situated in the initial site of
involvement. However, live microorganisms may be present
in these nodes and remain dormant for many  years, until
some other episode of immunosuppression happens and the
disease can be activated.11
Only about 5–10% of TB patients’ progress from infec-
tion to active disease and a coexisting immunosuppression
is often responsible. In rare situations, active TB may man-
ifest on primary infection. However, the disease activation
usually develops in other stages, from the reactivation of
the microorganism in a previously infected person, such
reactivation is characteristically associated with a compro-
mised host defense system, it may cause lung disease and
is called secondary tuberculosis. Granulomatous lesions may
promote diffuse dissemination through the vascular system
by tubercle bacilli, which may result in liver, renal, gastroin-
testinal and meninges involvement.1,3,11,12C BY-NC-ND (http://creativecommons.org/licenses/by-nc-nd/4.0/).
The extrapulmonary tuberculosis is about 25% of TB
lesions, 10–35% are found in the region of the head and neck
and 0.2–1.5% in the oral cavity.8 The most common extrapul-
monary regions in the head and neck are the cervical lymph
nodes, followed by the larynx and ear. The regions much less
common are nasal cavity, nasopharynx, oral, parotid gland,
esophagus and spine.11
In the last two decades due to decreased treatment adher-
ence and control of TB cases and with the advent of AIDS,
there is the development of multi-resistant of Koch bacil-
lus, occurring gradually, increasing the number of diseases
cases, resulting in pharyngo-laryngeal lesions, associated or
isolated.13
The tuberculosis lesions in the oral cavity are rare and may
occur anywhere, being more  frequent in tongue, palate, lips,
mucosa, gums, brake, jaw bones, periapical region, tonsils,
uvula, pharynx and larynx can manifest as a chronic irregular
ulcer, shallow or deep, painless, vegetating surface, with
numerous yellowish submucosal points (granules of Trélat),
tending to size increase slowly and progress to deep ulcers on
the basis of purulent lesions, containing active microorgan-
isms and highly infectious.3,8,10,11
The presentations include areas of nodular leukoplastic,
it may also occur as a granuloma, osteomyelitis, or salivary
gland disease.8
The oral lesions of primary tuberculosis usually involve
gums, mucobucal sulcus and inﬂammation areas adjacent
tooth extraction sites, and the secondary tuberculosis oral
lesions occur in the tongue, palate and lips, and may involve
the maxillary bones, occurring microorganism penetrations
in the area and periapical inﬂammation through the blood-
stream or through a pulp exposed to the oral environment.3
Usually it is associated with lymph node regionalized. The
tuberculosis osteomyelitis in the jaw has been reported and
appears as not deﬁned radiolucent areas.3,11
It is important to note that infectious oral ulcers may
present a similar shape to the other ulcerative oral cavity
lesions, for that reason there is the need of microscopic diag-
nosis, in conjunction with tuberculin skin test (Mantoux), or
sputum culture.8,10
Case  report
Male patient, 43 years old, dark skin, heterosexual, withStudy and Treatment for Patients with Special Needs (CEAPE)
– Paulista University – Indianapolis Campus – São Paulo
– Brazil, anamnesis report showed illicit drugs addiction,
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Fig. 1 – intraoral clinical examination observed oral lesions
in hard and soft palate, in the oropharynx, extending
tonsillar pillars, like painful irregular ulcer with yellowish
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Fig. 2 – improvement clinical features after application ofoints called beads Trélat.
lcoholic and smoking habits, with psychiatric diagnosis
f Panic Disorder and fear of death, treated with Fluoxe-
ine 20 mg  and Rivotril 2 mg daily, intending to restart the
reatment of neuro-tuberculosis and pulmonary tuberculo-
is for the third time, reporting to be bacillus resistant
ue to the lack of adherence to recommended treatment,
ecause the patient had abandoned the treatment by choice
very time clinical condition improved, occurring subsequent
ecurrence, exacerbated complication, aggravating the con-
ition. Test values performed were done 2 months after
howing lymphocyte CD4 = 75 cells/mm3 blood and viral load
56,000 copies per mm3 of blood. Dental treatment was done
n our clinical service and this time sought solution to the
ral lesion that assailed 2 weeks ago. During intraoral clin-
cal examination, oral lesions were observed in hard and
oft palate, in the oropharynx, extending tonsillar pillars,
emonstrating painful irregular ulcer with yellowish points
alled nodules of Trélat, those injuries promote speech,
wallowing and feeding problems, intensifying the drop in
heir immune resistance (Fig. 1). He also presented gener-
lized lymphadenopathy in cervical chain, weight loss of
2 pounds in one year, hemoptysis constant, local pain,
ever and cough. He reported that the treatment of tuber-
ulosis associated with antiretroviral therapy (HAART), has
reviously caused side effects of allergic reactions maculo-
apular rash, elevated transaminases and later exacerbated
ffects of Stevens Johnson Syndrome, where once again the
atient discontinued therapy, opposite the table shown at that
ime was reversed with Diprospan® (betamethasone dipro-
ionate + betamethasone disodium phosphate) 3 ampoules
ntramuscular (IM) applied every 24 h. The adjuvant treatment
or oral lesions was the Elixir Dexamethasone (Decadron®)
 5 mouthwash twice a day for 2 days, on the second day
egan application of low power diode laser Gallium Aluminumlow power diode laser in oral lesions.
Arsenide (GaAIAs) with a wavelength of 790 nm,  power 30 mW,
applied for 2 min  and 20 s punctually, in each clinical lesion
with energy density of 4 J/cm2 each point. The next appli-
cation had shown improvement of clinical features and the
patient had reported comfort in the oral cavity, pain and
burning decrease, facilitating swallowing and feeding (Fig. 2),
laser therapy provided anti-inﬂammatory, analgesic, repair
tissue and bactericidal. Oral treatment includes orientation
for the patient to return to the medical service for urgent
resumption of treatment and clinical follow-up. On a return
visit, 20 days after 1st ofﬁce visit he brought the new search
results sputum positive culture for M.  tuberculosis in 3 samples,
research Baar also positive and chest’s X-ray (Fig. 3). Other
tests were also conducted to: Hepatitis C, Hepatitis B, toxo-
plasmosis, cytomegalovirus, syphilis, all negative. Currently
patients do not follow HAART and tuberculosis therapy proto-
cols correctly, making the number of extras occurrences grow.
The antiretroviral medications administered are Efavirenz
and Biovir, the complex B vitamin and thiamine, and anti-
tuberculin drugs Rifampicin, Isoniazid and Ethambutol. The
deﬁnition of preferred or alternative regimens followed three
criteria: scientiﬁc rationale, efﬁcacy, tolerability and clinical
experience of the service that comes. After initiation of ther-
apy, the patient presented an excellent grip, keeping the bond
with the services and there was no negative complication
s that would lead to treatment dropout and further improve-
ment was evident in the general and oral health, with weight
gain, stimulating the proceed with the recommended treat-
ment protocols.
DiscussionHIV infection is an important modiﬁer factor for increasing
the incidence of clinic tuberculosis due to the alteration of
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Fig. 3 – Chest’s X-ray. Patient had sputum positive culture
for M.  tuberculosis and research Baar positive too.
r
3. Ribeiro ACP, Miranda KCL. Vivência do paciente comT lymphocyte. The antituberculosis therapy is performed
when the disease is active in other organs such as the lungs,
the therapy of choice is still the Isoniazid (INH) and rifampin
however there are many  controversies regarding Isoniazid
that may induce hepatotoxicity. During the treatment, tests
should be frequent for liver function control, those with
active disease need combination with chemotherapy.1,2 In
addition, several factors have exacerbated the spread of the
disease, such as tuberculosis transmission among people liv-
ing in bad conditions or poor health systems, and bad public
health infrastructure.11 We  cannot disregard the impact of
co-infection TB/HIV in patients life, since both diseases are
developed over the years, and are able to bring many  preju-
dices that inﬂuence signiﬁcantly their life quality.3
If the professional suspects of any form of tuberculosis,
the patient should be referred to the specialist for clinical and
laboratory evaluation and oral lesions usually are solved with
systemic treatment.4
Patients with disseminated tuberculosis are treated with
INH, rifampin and pyrazinamide. Studies show that ethnicit,
sex gender and age should be considered to decide about INH
prescription.14
Oral lesions of tuberculosis are uncommon in most cases
appearing as a chronic and painless ulcer, involving the
region of gums, mucobucal sulcus and inﬂammatory areas
adjacent tooth extraction sites, ulcers may be deep or
shallow, tending to increase size slowly.1,11 Tongue ulcer
may be the only manifestation of mycobacterial infec-
tion suggestive of tuberculosis in patients with HIV/AIDS,
which may occur because of a recurrence episode of TB
ganglionic.15
Most secondary infection causes lung injury. It is unclear
whether the affection occurs from hematogenous spread or by
exposure to contaminated catarrhal secretion. The discovery
of active pulmonary tuberculosis as a result of the investi-
gation of oral lesions occur, and it is not uncommon, and a c . 2 0 1 6;3 8(3):171–175
primary oral tuberculosis, without pulmonary involvement is
rare.11
Conclusion
Tuberculosis transmission occurs through individuals
infected, by aerosol, droplets and direct and indirect contact.
In this situation, the dentist needs to be aware about Biosafety
Universal Standards avoiding cross-contamination in work-
place. It is important to consider tuberculosis as differential
diagnosis of oral lesions. We emphasize the importance of
a correct diagnosis considering anamnesis, devoid of fear
and prejudices, improving the patient life quality, facilitating
adherence to recommended treatments.
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